Share this article
Go deeper with GlobalData
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.
Belgium-based molecular diagnostics company Biocartis has secured Emergency Use Authorisation (EUA) from the US Food and Drug Administration (FDA) for its Idylla Ebola Virus Triage Test (Idylla EBOV Test) to detect the Ebola Zaire virus in patients.
July 5, 2016